PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 256 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,208,915 | -25.2% | 39,404 | -2.3% | 0.01% | -20.0% |
| Q2 2023 | $1,616,905 | -3.4% | 40,352 | -1.6% | 0.02% | -11.8% |
| Q1 2023 | $1,674,189 | +140470.0% | 41,024 | +33.0% | 0.02% | -5.6% |
| Q4 2022 | $1,191 | -99.9% | 30,846 | -6.4% | 0.02% | -35.7% |
| Q3 2022 | $1,753,000 | -8.5% | 32,959 | +0.4% | 0.03% | -9.7% |
| Q2 2022 | $1,915,000 | -20.5% | 32,841 | +4.0% | 0.03% | -6.1% |
| Q1 2022 | $2,410,000 | +24.7% | 31,580 | -1.7% | 0.03% | +37.5% |
| Q4 2021 | $1,932,000 | +4.9% | 32,115 | -2.3% | 0.02% | +4.3% |
| Q3 2021 | $1,842,000 | -7.5% | 32,885 | +0.2% | 0.02% | 0.0% |
| Q2 2021 | $1,991,000 | -13.3% | 32,809 | +0.1% | 0.02% | -17.9% |
| Q1 2021 | $2,297,000 | +10.1% | 32,770 | -6.1% | 0.03% | +7.7% |
| Q4 2020 | $2,087,000 | -13.0% | 34,883 | -12.6% | 0.03% | -18.8% |
| Q3 2020 | $2,400,000 | +37.5% | 39,925 | +20.0% | 0.03% | +14.3% |
| Q2 2020 | $1,746,000 | +46.7% | 33,279 | -6.2% | 0.03% | +27.3% |
| Q1 2020 | $1,190,000 | -8.0% | 35,496 | +24.4% | 0.02% | +10.0% |
| Q4 2019 | $1,293,000 | +19.8% | 28,544 | +0.7% | 0.02% | +17.6% |
| Q3 2019 | $1,079,000 | – | 28,339 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |